NCT07108400 Efficacy of a Combination of Ultrasound-guided Intra-articular Injections of Hyaluronic Acid, High-power Laser Therapy and Rehabilitation on Functioning in Patients Affected by Hip Osteoarthritis.
| NCT ID | NCT07108400 |
| Status | Recruiting |
| Phase | — |
| Sponsor | De Sire Alessandro |
| Condition | Hip Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 57 participants |
| Start Date | 2022-03-17 |
| Primary Completion | 2025-08-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 57 participants in total. It began in 2022-03-17 with a primary completion date of 2025-08-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
High-power laser therapy (HPLT) is effective in treating musculoskeletal conditions, reducing pain and improving joint functionality. This randomized controlled trial (RCT) aimed to explore the effectiveness of a combination of HPLT, hyaluronic acid injections, and rehabilitation for patients with hip osteoarthritis.
Eligibility Criteria
Inclusion Criteria: * Age over 18 years * Diagnosis of hip OA (stage ≤ 3 according to the Kellgren and Lawrence classification) * Hip pain assessed with the Numeric Rating Scale ≥ 4 * Body mass index (BMI) less than 30 kg/m² * Suspension of anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, muscle relaxants or any other therapy that could interfere with the study assessments. Exclusion Criteria: * Mini-Mental State Examination (MMSE) score \< 24 * Concurrent treatment with an-ti-inflammatory drugs or rehabilitation therapies; Rheumatoid arthritis.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07108400 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Hip Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07108400 currently recruiting?
Yes, NCT07108400 is actively recruiting participants. Contact the research team at alessandro.desire@unicz.it for enrollment information.
Where is the NCT07108400 trial being conducted?
This trial is being conducted at Catanzaro, Italy, Catanzaro, Italy.
Who is sponsoring the NCT07108400 clinical trial?
NCT07108400 is sponsored by De Sire Alessandro. The trial plans to enroll 57 participants.